Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3

The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients

(2013) Mattias Mandorfer et al.   AIDS

In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use

(2013) Andrea D Branch et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Strategies for assignment of HIV/HCV genotype 1-coinfected patients to either dual-therapy or direct-acting antiviral agent based triple therapy

(2013) Mattias Mandorfer et al.   ANTIVIRAL THERAPY

A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response

(2013) Ning Ding et al.   CELL

Prediction of Liver Complications in Patients With Hepatitis C Virus-Related Cirrhosis With and Without HIV Coinfection: Comparison of Hepatic Venous Pressure Gradient and Transient Elastography

(2013) L. Perez-Latorre et al.   CLINICAL INFECTIOUS DISEASES

Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis

(2013) Mazen Noureddin et al.   HEPATOLOGY

Impact of vitamin D insufficiency on insulin homeostasis and beta cell function in nondiabetic male HIV-infected patients

(2013) O Moreno-Pérez et al.   HIV MEDICINE

Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration

(2013) L Castera et al.   HIV MEDICINE

Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients

(2013) María Guzmán-Fulgencio et al.   JOURNAL OF INFECTION

Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels

(2013) M. Mandorfer et al.   JOURNAL OF VIRAL HEPATITIS

Role ofFDFT1polymorphism for fibrosis progression in patients with chronic hepatitis C

(2013) Albert F. Stättermayer et al.   LIVER INTERNATIONAL

Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease

(2013) Jaividhya Dasarathy et al.   LIVER INTERNATIONAL

1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1(I) collagen expression and type I collagen formation

(2013) James J. Potter et al.   LIVER INTERNATIONAL

Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients

(2012) Mark W. Hull et al.   AIDS

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV–hepatitis C virus coinfected patients

(2012) Mattias Mandorfer et al.   AIDS

A prospective evaluation of pulmonary, systemic and hepatic hemodynamics in HIV-HCV coinfected patients prior and after antiviral therapy with pegylated interferon and ribavirin

(2012) Thomas Reiberger et al.   ANTIVIRAL THERAPY

Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Virologic Response in Patients With Genotype 1 Chronic Hepatitis C

(2012) Salvatore Petta et al.   Clinical Gastroenterology and Hepatology

Factors Associated With Discordance Between Absolute CD4 Cell Count and CD4 Cell Percentage in Patients Coinfected With HIV and Hepatitis C Virus

(2012) M. W. Hull et al.   CLINICAL INFECTIOUS DISEASES

The Influence of Portal Pressure on the Discordance Between Absolute CD4+ Cell Count and CD4+ Cell Percentage in HIV/Hepatitis C Virus–Coinfected Patients

(2012) M. Mandorfer et al.   CLINICAL INFECTIOUS DISEASES

HCV Infection and Metabolic Syndrome: Which Is the Chicken and Which Is the Egg?

(2012) Francesco Negro   GASTROENTEROLOGY

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naïve patients infected with HCV genotype 1

(2012) Lawrence Serfaty et al.   GUT

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients

(2012) Juan Macías et al.   HEPATOLOGY

Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCV

(2012) Berkeley N. Limketkai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C

(2012) Albert Friedrich Stättermayer et al.   JOURNAL OF HEPATOLOGY

IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease

(2012) Salvatore Petta et al.   JOURNAL OF HEPATOLOGY

D-livering the message: The importance of vitamin D status in chronic liver disease

(2012) Matthew T. Kitson et al.   JOURNAL OF HEPATOLOGY

IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus

(2012) María Guzmán-Fulgencio et al.   JOURNAL OF INFECTION

Prospective Associations of Vitamin D With β-Cell Function and Glycemia

(2011) Sheena Kayaniyil et al.   DIABETES

IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients

(2011) Berit A. Payer et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats

(2011) S. Abramovitch et al.   GUT

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

(2011) Eric Trépo et al.   HEPATOLOGY

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

(2011) Pierre-Yves Bochud et al.   HEPATOLOGY

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

(2011) Silvia Sookoian et al.   HEPATOLOGY

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

(2011) Michael F. Holick et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis

(2011) Benjamin Terrier et al.   JOURNAL OF HEPATOLOGY

Concomitant Highly Active Antiretroviral Therapy Leads to Smaller Decline and Faster Recovery of CD4+ Cell Counts During and After Pegylated Interferon Plus Ribavirin Therapy in HIV–Hepatitis C Virus Coinfected Patients

(2011) T. Reiberger et al.   JOURNAL OF INFECTIOUS DISEASES

Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin DReceptor (NR 1I1) variants on fibrosis progression rate in HCV patients

(2011) Katharina Baur et al.   LIVER INTERNATIONAL

Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C Virus

(2010) Tinsay A. Woreta et al.   GASTROENTEROLOGY

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

(2010) Luca Valenti et al.   HEPATOLOGY

Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients

(2010) Marie-Louise C. Vachon et al.   JOURNAL OF HEPATOLOGY

Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene

(2009) K. Kantartzis et al.   DIABETES

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

(2009) Gary L. Davis et al.   GASTROENTEROLOGY

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus

(2009) Juan Macías et al.   HEPATOLOGY

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

(2009) T. Reiberger et al.   JOURNAL OF VIRAL HEPATITIS

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers

(2009) M. Sánchez-Conde et al.   JOURNAL OF VIRAL HEPATITIS

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

(2008) Hla-Hla Thein et al.   AIDS

Validation and Comparison of Simple Noninvasive Indexes for Predicting Liver Fibrosis in HIV-HCV-Coinfected Patients: ANRS CO3 Aquitaine Cohort

(2008) Marc-Arthur Loko et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

(2008) Hla-Hla Thein et al.   HEPATOLOGY

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

(2008) Stefano Romeo et al.   NATURE GENETICS